{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:22:51Z","timestamp":1791177771777,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007920.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000}}],"reference-count":84,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007920.pub4","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T08:38:58Z","timestamp":1680511138000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-vascular endothelial growth factor for neovascular glaucoma"],"prefix":"10.1002","volume":"2023","author":[{"given":"Thanitsara","family":"Rittiphairoj","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology; University of Colorado Denver Anschutz Medical Campus; Aurora CO USA"},{"name":"Division of Health Systems Management, Department of Community Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Roberti","sequence":"additional","affiliation":[{"name":"Ophthalmology; Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuele","family":"Michelessi","sequence":"additional","affiliation":[{"name":"Ophthalmology; Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia-IRCCS; Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"10.1002\/14651858.CD007920.pub4-BIB0001|cit1","unstructured":"Efficacy and safety of intravitreal avastin in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=82392"},{"issue":"1","key":"10.1002\/14651858.CD007920.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.12493","article-title":"Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up","volume":"93","author":"Arcieri","year":"2015","journal-title":"Acta Ophthalmologica"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0003|cit3","first-page":"627 (Poster A47","article-title":"Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation - preliminary report","volume":"51","author":"Arcieri","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1002\/14651858.CD007920.pub4-BIB0004|cit4","first-page":"1855","article-title":"Anti-VEGF medicine with PRP for neovascular glaucoma","volume":"18","author":"Deng","year":"2018","journal-title":"International Eye Science\u00a0"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0005|cit5","first-page":"2398","article-title":"Efficacy and safety of intravitreal aflibercept injection (IAI) in neovascular glaucoma (NVG): the VEGA study","volume":"60","author":"Higashide","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s12325-020-01579-5","article-title":"Intravitreal aflibercept in Japanese patients with neovascular glaucoma: the VEGA randomized clinical trial","volume":"38","author":"Inatani","year":"2021","journal-title":"Advances in Therapy\u00a0"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0007|cit7","unstructured":"Japanese phase 3 study of aflibercept in neovascular glaucoma patients clinicaltrials.gov\/ct2\/show\/NCT02396316"},{"issue":"10","key":"10.1002\/14651858.CD007920.pub4-BIB0008|cit8","first-page":"1763","article-title":"Clinical research of retinal laser photocoagulation and ranibizumab on the treatment of neovascular glaucoma","volume":"15","author":"Jiang","year":"2015","journal-title":"International Eye Science"},{"issue":"9","key":"10.1002\/14651858.CD007920.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IJG.0b013e318259aec4","article-title":"Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma","volume":"22","author":"Mahdy","year":"2013","journal-title":"Journal of Glaucoma"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.18240\/ijo.2021.03.20","article-title":"Intracameral anti-VEGF injection for advanced neovascular glaucoma after vitrectomy with silicone oil tamponade","volume":"14","author":"Bai","year":"2021","journal-title":"International Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0011|cit11","unstructured":"Adjunctive with intravitreal injection of ranibizumab before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: a prospective randomized controlled study trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-IPR-15006695"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0012|cit12","unstructured":"Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-OPN-16008147"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pdi.2268","article-title":"Bevacizumab","volume":"37","author":"Dorrans","year":"2020","journal-title":"Practical Diabetes"},{"issue":"4","key":"10.1002\/14651858.CD007920.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/APO.0000000000000248","article-title":"Intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy versus visco-trabeculotomy in management of neovascular glaucoma","volume":"8","author":"Elwehidy","year":"2019","journal-title":"Asia-Pacific Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0015|cit15","unstructured":"Randomised controlled trial of intravitreal Bevacizumab vs. conventional treatment for rubeotic glaucoma trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2007-000585-21-IE"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0016|cit16","unstructured":"An open label, prospective, monocenter, prove of concept study to evaluate the short- and long-term effects of 0.5 mg intraocular Ranibizumab (Lucentis) injections as adjuvant for patients with rubeosis and neovascular glaucoma trialsearch.who.int\/Default.aspx"},{"issue":"9","key":"10.1002\/14651858.CD007920.pub4-BIB0017|cit17","first-page":"1617","article-title":"Conbercept combined with PRP in the treatment of early nevoascular glaucoma secondary to central retinal vein occlusion","volume":"20","author":"Gou","year":"2020","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0018|cit18","unstructured":"Effects of bevacizumab in Ahmed glaucoma valve surgery trialsearch.who.int\/Trial2.aspx?TrialID=IRCT2016042527595N1"},{"issue":"6","key":"10.1002\/14651858.CD007920.pub4-BIB0019|cit19","first-page":"988","article-title":"Ranibizumab combined with vitrectomy for DR with neovascular glaucoma","volume":"19","author":"Jiang","year":"2019","journal-title":"International Eye Science"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0020|cit20","unstructured":"The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received an additional bevacizumab treatment after the surgery trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000000895"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0021|cit21","unstructured":"The study for surgical outcome of trabeculectomy for neovascular glaucomatous patients who received bevacizumab treatment before the surgery trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000001136"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0022|cit22","unstructured":"Proteomic analyses of regulating factors of neovascular ocular inflammation and retinal edema trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000003854"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0023|cit23","unstructured":"The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases trialsearch.who.int\/Trial2.aspx?TrialID=JPRN-UMIN000013974"},{"issue":"5","key":"10.1002\/14651858.CD007920.pub4-BIB0024|cit24","first-page":"847","article-title":"Clinical observation of new EX-PRESS glaucoma drainage combined with Ranibizumab for neovascular glaucoma","volume":"20","author":"Liu","year":"2020","journal-title":"International Eye Science"},{"issue":"10","key":"10.1002\/14651858.CD007920.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.18240\/ijo.2019.10.08","article-title":"Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma","volume":"12","author":"Muhsen","year":"2019","journal-title":"International Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0026|cit26","unstructured":"Intravitreal ranibizumab (Lucentis\u00ae) for neovascular glaucoma - a randomized controlled study clinicaltrials.gov\/ct2\/show\/NCT02914626"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0027|cit27","unstructured":"Aflibercept as adjunctive treatment for filtration surgery in neovascular glaucoma ClinicalTrials.gov\/show\/NCT04970251"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0028|cit28","unstructured":"Clinical study of the use of bevacizumab in glaucoma surgery trialsearch.who.int\/Trial2.aspx?TrialID=RBR-9wkw73j"},{"issue":"6","key":"10.1002\/14651858.CD007920.pub4-BIB0029|cit29","first-page":"521","article-title":"Effect of conbercept combined with trabeculectomy on aqueous humor VEGF and SDF-1 levels for patients with neovascular glaucoma","volume":"26","author":"Song","year":"2019","journal-title":"Chinese Journal of Pharmaceutical Biotechnology"},{"issue":"20","key":"10.1002\/14651858.CD007920.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1097\/CM9.0000000000000482","article-title":"Early vitrectomy combined with pan retinal photocoagulation, anti-vascular endothelial growth factor, and gradual cyclophotocoagulation for treatment of neovascular glaucoma","volume":"132","author":"Sun","year":"2019","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0031|cit31","unstructured":"Risk factors associated hyphema after intravitreal injection of bevacizumab before trabeculectomy for neovascular glaucoma trialsearch.who.int\/Trial2.aspx?TrialID=TCTR20160826002"},{"issue":"1","key":"10.1002\/14651858.CD007920.pub4-BIB0032|cit32","first-page":"143","article-title":"Effect of modified Ahmed drainage valve implantation combined with conbercept in the treatment of neovascular glaucoma","volume":"20","author":"Wu","year":"2020","journal-title":"International Eye Science\u00a0"},{"issue":"8","key":"10.1002\/14651858.CD007920.pub4-BIB0033|cit33","first-page":"1399","article-title":"Conbercept combined with 25G vitrectomy and trabeculectomy for NVG secondary to PDR and VH","volume":"20","author":"Yang","year":"2020","journal-title":"International Eye Science"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0034|cit34","first-page":"481","article-title":"Effectiveness of anti-VEGF agents in patients with retinal vein occlusion","volume":"14","author":"Yuryevich","year":"2019","journal-title":"Medical News of North Caucasus"},{"issue":"5","key":"10.1002\/14651858.CD007920.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s10792-021-01691-7","article-title":"Ahmed glaucoma valve implantation with and without subconjunctival bevacizumab in refractory glaucoma","volume":"41","author":"Zarei","year":"2021","journal-title":"International Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD007920.pub4-BIB0036|cit36","first-page":"1809","article-title":"Effect on vision and complications of conbercept combined with EX-PRESS glaucoma drainage device implantation for patients with neovascular glaucoma","volume":"20","author":"Zhao","year":"2020","journal-title":"International Eye Science"},{"issue":"22","key":"10.1002\/14651858.CD007920.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007920.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease","volume":"18","author":"Andreoli","year":"2007","journal-title":"Current Opinion in Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12325-016-0461-z","article-title":"Current perspectives on the use of anti-VEGF drugs as adjuvant therapy in glaucoma","volume":"34","author":"Andr\u00e9s-Guerrero","year":"2017","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","article-title":"Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment","volume":"26","author":"Avery","year":"2006","journal-title":"Retina"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0161-6420(88)33212-4","article-title":"A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy","volume":"95","author":"Blankenship","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0042|cit42","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0043|cit43","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"issue":"5","key":"10.1002\/14651858.CD007920.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0161-6420(03)00103-9","article-title":"Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma","volume":"110","author":"Delgado","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007920.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0161-6420(84)34123-9","article-title":"Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy","volume":"91","author":"Doft","year":"1984","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1002\/14651858.CD007920.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"e9897","DOI":"10.1097\/MD.0000000000009897","article-title":"Effectiveness of multiple therapeutic strategies in neovascular glaucoma patients: a PRISMA-compliant network meta-analysis","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007920.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/IAE.0b013e3181679c0b","article-title":"Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma","volume":"28","author":"Ehlers","year":"2008","journal-title":"Retina"},{"issue":"1","key":"10.1002\/14651858.CD007920.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1442-9071.2007.01667.x","article-title":"Use of antivascular agents for neovascular glaucoma: benefits beyond pressure?","volume":"36","author":"Gandhi","year":"2008","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0049|cit49","unstructured":"GRADEpro GDT McMaster University (developed by Evidence prime)"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bjo.2008.145714","article-title":"Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma","volume":"93","author":"Grover","year":"2009","journal-title":"British Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"435\u201341","DOI":"10.1177\/112067210901900318","article-title":"The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma","volume":"19","author":"Gupta","year":"2009","journal-title":"European Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD007920.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3341\/kjo.2017.0017","article-title":"Efficacy and safety of intracameral bevacizumab for treatment of neovascular glaucoma","volume":"31","author":"Ha","year":"2017","journal-title":"Korean Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000068980","article-title":"Management of central retinal vein occlusion","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0054|cit54","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0055|cit55","unstructured":"Higgins JPT Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0056|cit56","unstructured":"Holger JS Julian PTH Gunn EV Paul G Elie AA Nicole S Cochrane GRADEing Methods Group (formerly Applicability and Recommendations Methods Group) and the Cochrane Statistical Methods Group Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD007920.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/jop.2014.0108","article-title":"Beneficial effects of adjuvant intravitreal bevacizumab injection on outcomes of Ahmed glaucoma valve implantation in patients with neovascular glaucoma: systematic literature review","volume":"31","author":"Hwang","year":"2015","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"39","key":"10.1002\/14651858.CD007920.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e27326","DOI":"10.1097\/MD.0000000000027326","article-title":"Effect of anti-vascular endothelial growth factor on the surgical outcome of neovascular glaucoma: an overview and meta-analysis","volume":"100","author":"Hwang","year":"2021","journal-title":"Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007920.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s12325-020-01580-y","article-title":"Efficacy and safety of intravitreal aflibercept injection in Japanese patients with neovascular glaucoma: outcomes from the VENERA study","volume":"38","author":"Inatani","year":"2021","journal-title":"Advances in Therapy"},{"issue":"4","key":"10.1002\/14651858.CD007920.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10792-013-9875-7","article-title":"The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma","volume":"34","author":"Kang","year":"2014","journal-title":"International Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD007920.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00417-006-0321-7","article-title":"Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma","volume":"244","author":"Kiuchi","year":"2006","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"9-10","key":"10.1002\/14651858.CD007920.pub4-BIB0063|cit63","first-page":"240","article-title":"Cyclocryocoagulation in treatment of neovascular glaucoma","volume":"126","author":"Kovacic","year":"2004","journal-title":"Lijecnicki Vjesnik"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004918.pub2","article-title":"Aqueous shunts for glaucoma","author":"Minckler","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2147\/OPTH.S137470","article-title":"Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience","volume":"11","author":"Noor","year":"2017","journal-title":"Clinical Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/eye.2015.259","article-title":"Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab","volume":"30","author":"Olmos","year":"2016","journal-title":"Eye"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF01694549","article-title":"Contribution to the teachings of hemorrhagic glaucoma","volume":"17","author":"Pagenstecher","year":"1871","journal-title":"Graefe's Archive for Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0068|cit68","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma: a review","volume":"2","author":"Rodrigues","year":"2016","journal-title":"International Journal of Retina & Vitreous"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005139.pub4","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","author":"Solomon","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD007920.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2337\/diacare.19.11.1306b","article-title":"Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated","volume":"19","author":"Sone","year":"1996","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","article-title":"Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma","volume":"105","author":"Tripathi","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD007920.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/B978-1-4160-0016-7.50216-2","volume-title":"Albert and Jakobiec's Principles and Practice of Ophthalmology","volume":"2","author":"Tsai","year":"2008"},{"issue":"9","key":"10.1002\/14651858.CD007920.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","article-title":"Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases","volume":"115","author":"Wakabayashi","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD007920.pub4-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002897.pub2","article-title":"Intraoperative mitomycin C for glaucoma surgery","author":"Wilkins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007920.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5301\/ejo.5000089","article-title":"Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab","volume":"22","author":"Wittstrom","year":"2012","journal-title":"European Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001132","article-title":"Postoperative 5-fluorouracil for glaucoma surgery","author":"Wormald","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007920.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.eye.6702125","article-title":"Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma","volume":"21","author":"Yalvac","year":"2007","journal-title":"Eye"},{"issue":"5","key":"10.1002\/14651858.CD007920.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma","volume":"16","author":"Yazdani","year":"2007","journal-title":"Journal of Glaucoma"},{"issue":"8","key":"10.1002\/14651858.CD007920.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/IJG.0b013e3181997211","article-title":"Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial","volume":"18","author":"Yazdani","year":"2009","journal-title":"Journal of Glaucoma"},{"issue":"7","key":"10.1002\/14651858.CD007920.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/IJG.0000000000000241","article-title":"Clinical outcomes of Ahmed glaucoma valve implantation with or without intravitreal bevacizumab pretreatment for neovascular glaucoma: a systematic review and meta-analysis","volume":"25","author":"Zhou","year":"2016","journal-title":"Journal of Glaucoma"},{"issue":"3","key":"10.1002\/14651858.CD007920.pub4-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007920","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","author":"Simha","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007920.pub4-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007920.pub2","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","author":"Simha","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007920.pub4-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007920.pub3","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","author":"Simha","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:35:16Z","timestamp":1758810916000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007920.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007920.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]}}}